Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2020
Historique:
received: 26 08 2019
revised: 12 11 2019
accepted: 23 12 2019
pubmed: 14 4 2020
medline: 16 11 2021
entrez: 14 4 2020
Statut: ppublish

Résumé

The Amyloid Imaging to Prevent Alzheimer's Disease (AMYPAD) Prognostic and Natural History Study (PNHS) aims at understanding the role of amyloid imaging in the earliest stages of Alzheimer's disease (AD). AMYPAD PNHS adds (semi-)quantitative amyloid PET imaging to several European parent cohorts (PCs) to predict AD-related progression as well as address methodological challenges in amyloid PET. AMYPAD PNHS is an open-label, prospective, multi-center, cohort study recruiting from multiple PCs. Around 2000 participants will undergo baseline amyloid positron emission tomography (PET), half of whom will be invited for a follow-up PET 12 at least 12 months later. Primary include several amyloid PET measurements (Centiloid, SUVr, BP Determining the role of amyloid PET for the understanding of this complex disease and potentially improving secondary prevention trials.

Identifiants

pubmed: 32281303
doi: 10.1002/alz.12069
pmc: PMC7984341
doi:

Substances chimiques

Amyloid 0
Biomarkers 0

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

750-758

Informations de copyright

© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Références

Alzheimers Dement (N Y). 2018 May 03;4:195-214
pubmed: 29955663
Nature. 2016 Aug 31;537(7618):50-6
pubmed: 27582220
Neuroimage. 2010 Jan 15;49(2):1316-25
pubmed: 19815080
J Nucl Med. 2017 Jul;58(7):1019-1024
pubmed: 28522743
Neurology. 2017 Nov 14;89(20):2031-2038
pubmed: 29046362
Alzheimers Dement. 2018 Oct;14(10):1281-1292
pubmed: 29792874
J Nucl Med. 2013 Sep;54(9):1570-6
pubmed: 23940304
N Engl J Med. 2014 Jan 23;370(4):322-33
pubmed: 24450891
EJNMMI Res. 2019 Mar 27;9(1):32
pubmed: 30919133
Alzheimers Dement. 2015 Sep;11(9):1050-68
pubmed: 25457431
JAMA Neurol. 2018 Aug 1;75(8):970-979
pubmed: 29710225
JAMA. 2017 Oct 10;318(14):1393-1394
pubmed: 29049582
J Alzheimers Dis. 2018;64(s1):S3-S22
pubmed: 29562511
Brain. 2015 Jul;138(Pt 7):2020-33
pubmed: 25953778
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Alzheimers Dement. 2015 Aug;11(8):975-85
pubmed: 26141264
Neurobiol Aging. 2018 Apr;64:76-84
pubmed: 29353101
N Engl J Med. 2018 May 3;378(18):1691-1703
pubmed: 29719179
Lancet Psychiatry. 2016 Feb;3(2):179-86
pubmed: 26683239
Neuron. 2013 Dec 18;80(6):1347-58
pubmed: 24360540
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
J Nucl Med. 2009 Aug;50(8):1251-9
pubmed: 19617318
Alzheimers Dement. 2018 Nov;14(11):1387-1396
pubmed: 30420035
Alzheimers Res Ther. 2018 Aug 4;10(1):75
pubmed: 30075734
Alzheimers Res Ther. 2016 May 12;8(1):18
pubmed: 27176461
JAMA. 2017 Jun 13;317(22):2305-2316
pubmed: 28609533
N Engl J Med. 2018 Jan 25;378(4):321-330
pubmed: 29365294
Int J Epidemiol. 2017 Feb 1;46(1):103-105
pubmed: 27272186
Lancet Neurol. 2011 May;10(5):424-35
pubmed: 21481640
Alzheimers Dement. 2020 May;16(5):750-758
pubmed: 32281303
Brain. 2016 Apr;139(Pt 4):1226-36
pubmed: 26936941
Alzheimers Dement. 2015 Sep;11(9):1121-2
pubmed: 25754460
J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
pubmed: 2384545
Neuroimage. 1997 Nov;6(4):279-87
pubmed: 9417971
Neurology. 2018 Nov 6;91(19):e1809-e1821
pubmed: 30305451
J Nucl Med. 2019 Apr;60(4):541-547
pubmed: 30315145
Alzheimers Dement (N Y). 2016 Mar 03;2(2):82-92
pubmed: 29067295
JAMA Neurol. 2019 Jul 17;:
pubmed: 31314895
Neurology. 2019 Jul 9;93(2):72-79
pubmed: 31167933
J Nucl Med. 2015 Aug;56(8):1199-205
pubmed: 26045309
Crit Rev Clin Lab Sci. 2020 Mar;57(2):99-113
pubmed: 31661652
Alzheimers Dement. 2020 Feb;16(2):283-291
pubmed: 31611055
Alzheimers Res Ther. 2019 Sep 12;11(1):78
pubmed: 31511058
Alzheimers Dement. 2019 Sep;15(9):1172-1182
pubmed: 31405824
J Intern Med. 2019 Oct;286(4):398-437
pubmed: 31286586

Auteurs

Isadora Lopes Alves (I)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Lyduine E Collij (LE)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Daniele Altomare (D)

Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Memory Clinic, University Hospital of Geneva, Geneva, Switzerland.

Giovanni B Frisoni (GB)

Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Memory Clinic, University Hospital of Geneva, Geneva, Switzerland.

Laure Saint-Aubert (L)

Department of Nuclear Medicine, Imaging Pole, Toulouse, University Hospital, Toulouse, France.
Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Pierre Payoux (P)

Department of Nuclear Medicine, Imaging Pole, Toulouse, University Hospital, Toulouse, France.
Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Miia Kivipelto (M)

Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Frank Jessen (F)

Department of Nuclear Medicine, University of Cologne, Cologne, Germany.

Alexander Drzezga (A)

Department of Nuclear Medicine, University of Cologne, Cologne, Germany.

Annebet Leeuwis (A)

Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Alzheimercenter, Amsterdam, the Netherlands.

Alle Meije Wink (AM)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Pieter Jelle Visser (PJ)

Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Alzheimercenter, Amsterdam, the Netherlands.

Bart N M van Berckel (BNM)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Philip Scheltens (P)

Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Alzheimercenter, Amsterdam, the Netherlands.

Katherine R Gray (KR)

IXICO Plc, London, United Kingdom.

Robin Wolz (R)

IXICO Plc, London, United Kingdom.

Andrew Stephens (A)

Life Molecular Imaging, GmbH, Berlin, Germany.

Rossella Gismondi (R)

Life Molecular Imaging, GmbH, Berlin, Germany.

Christopher Buckely (C)

GE Healthcare, Life Sciences, Amersham, United Kingdom.

Juan Domingo Gispert (JD)

Barcelona β Brain Research Center, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.

Mark Schmidt (M)

Janssen Pharmaceutica NV, Beerse, Belgium.

Lisa Ford (L)

Janssen Pharmaceutica RND, Titusville, New Jersey, USA.

Craig Ritchie (C)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Gill Farrar (G)

GE Healthcare, Life Sciences, Amersham, United Kingdom.

Frederik Barkhof (F)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, UCL, London, United Kingdom.

José Luis Molinuevo (JL)

Barcelona β Brain Research Center, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH